P920: EVALUATION OF EARLY PROGRESSIVE DISEASE (EPD) IN NEWLY DIAGNOSED MYELOMA PATIENTS AND IDENTIFICATION OF PROGNOSTIC FACTORS IN THE ERA OF MODERN THERAPIES. THE GREEK MYELOMA STUDY GROUP EXPERIENCE
Saved in:
Published in | HemaSphere Vol. 7; no. S3; pp. e6965838 - n/a |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
Lippincott Williams & Wilkins
08.08.2023
Wiley |
Online Access | Get full text |
Cover
Loading…
ISSN: | 2572-9241 2572-9241 |
---|---|
DOI: | 10.1097/01.HS9.0000970584.69658.38 |